Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/25/2026 | Q4 | $248.4M | -- | -- | $0.47 | -- |
| 11/05/2025 | Q3 | $251.7M | $269.2M | $0.52 | $0.53 | -$0.02 |
| 08/06/2025 | Q2 | $223.4M | $215.4M | $0.44 | $0.50 | -$0.07 |
| 04/29/2025 | Q1 | $165.3M | $172.3M | $0.30 | $0.35 | -$0.05 |
| 02/26/2025 | Q4 | $194.9M | $223.5M | $0.46 | $0.39 | $0.07 |
| 11/07/2024 | Q3 | $193.4M | $204M | -- | $0.37 | -- |
| 08/07/2024 | Q2 | $163M | $202.5M | $0.35 | $0.35 | -- |
| 05/08/2024 | Q1 | $153.8M | $152.2M | $0.26 | $0.33 | -$0.07 |
| 02/28/2024 | Q4 | $149.3M | $170.3M | $0.26 | $0.17 | $0.09 |
| 11/07/2023 | Q3 | -- | -- | $0.39 | $0.34 | $0.05 |
| 08/04/2023 | Q2 | -- | -- | $0.41 | $0.15 | $0.26 |
| 05/05/2023 | Q1 | -- | -- | $0.11 | $0.04 | $0.07 |
| 02/24/2023 | Q4 | -- | -- | $0.18 | $0.15 | $0.03 |
| 11/04/2022 | Q3 | -- | -- | $0.32 | $0.23 | $0.09 |
| 08/05/2022 | Q2 | -- | -- | $0.18 | $0.03 | $0.15 |
| 05/06/2022 | Q1 | -- | -- | -$0.10 | -- | -- |
| 02/25/2022 | Q4 | -- | -- | $0.23 | -- | -- |
| 11/04/2021 | Q3 | -- | -- | $0.15 | -- | -- |
| 08/05/2021 | Q2 | -- | -- | $0.10 | -- | -- |
| 05/06/2021 | Q1 | -- | -- | $0.08 | -- | -- |
| 02/25/2021 | Q4 | -- | -- | $0.13 | -- | -- |
| 11/05/2020 | Q3 | -- | -- | $0.13 | -- | -- |
| 08/05/2020 | Q2 | -- | -- | -$0.00 | -- | -- |
| 05/06/2020 | Q1 | -- | -- | $0.03 | -- | -- |
| 03/18/2020 | Q4 | -- | -- | $0.06 | -- | -- |
| 11/06/2019 | Q3 | -- | -- | $0.15 | -- | -- |
| 08/07/2019 | Q2 | -- | -- | $0.08 | -- | -- |
| 05/07/2019 | Q1 | -- | -- | $0.03 | -- | -- |
| 03/06/2019 | Q4 | -- | -- | $0.04 | -- | -- |
| 11/07/2018 | Q3 | -- | -- | $0.07 | -- | -- |
| 08/07/2018 | Q2 | -- | -- | $0.06 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$0.06 | -- | -- |
| 03/05/2018 | Q4 | -- | -- | $0.08 | -- | -- |
| 12/07/2017 | Q3 | -- | -- | -$0.02 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$0.01 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$0.09 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | $0.05 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | $0.02 | -- | -- |
ACM Research, Inc. reported $269.2M worth of top line sales in its most recent quarter.
ACM Research, Inc. announced earnings per share of $0.52 which represents a miss of analyst forecast a $0.53 per share.
ACM Research, Inc. reported $113.1M that represents $1.65 per share over the last quarter.
ACM Research, Inc.'s earnings are forecast to grow from $1.53 per share to $2.10 per share next year representing an increase of 19.7%.
ACM Research, Inc.'s next earnings date is February 25, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.